bf/NASDAQ:ONTX_icon.jpeg

NASDAQ:ONTX

Onconova Therapeutics, Inc.

  • Stock

USD

Last Close

1.00

02/04 20:00

Market Cap

14.84M

Beta: 1.77

Volume Today

1.25M

Avg: 588.32K

PE Ratio

−0.75

PFCF: −0.84

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other ant...Show More

Earnings

Earnings per Share (Estimate*)

-1500-1000-5005002015-03-262017-03-272019-03-262021-03-112023-03-16

Revenue (Estimate*)

5M10M15M2015-03-262017-03-272019-03-262021-03-112023-03-16

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.